image credit- shutterstock
Galderma has announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC region. The brand recently launched in Taiwan, will soon launch in Japan, and has received approval to launch in Singapore and South Korea, with planned market introduction in September and November, respectively.
This expansion follows Alastin’s recent launches in China and Australia and underscores Galderma’s continued investment in JPAC, a region characterised by advanced skincare practices and rapid growth in injectable aesthetics. This is increasing demand for integrated skincare solutions that support skin readiness, recovery and long-term quality.
Alastin addresses this need through its range of peri-procedural support and daily skincare products that amplify the skin’s natural regenerative abilities, supporting recovery and enhances visible outcomes of in-demand aesthetic procedures such as energy-based device and injectable treatments.
Nine products will be available in the JPAC region, including:
